Study suggests new drug candidate could treat both type 2 diabetes and bone loss

A new study has shown that a new class of drug candidates developed at The Scripps Research Institute increases bone mass by expanding bone formation (deposition of new bone) and bone turnover (a normal process of replacement of old bone).
Go to Source